{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:09:05Z","timestamp":1790352545070,"version":"4.1.0"},"reference-count":180,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-025-04461-y","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:19:39Z","timestamp":1760527179000},"page":"1098-1111","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Polycystic ovary syndrome and idiopathic central precocious puberty: two sides of the same coin?"],"prefix":"10.1007","volume":"90","author":[{"given":"Esmeralda","family":"Cela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Tarantino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Vincenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Tenuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Pozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Minnetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Sbardella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"issue":"Suppl 1","key":"4461_CR1","first-page":"695","volume":"13","author":"M Cisternino","year":"2000","unstructured":"Cisternino, M., et al. (2000). Etiology and age incidence of precocious puberty in girls: a multicentric study. J. Pediatr. Endocrinol. Metab., 13(Suppl 1), 695\u2013701.","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"12","key":"4461_CR2","doi-asserted-by":"publisher","first-page":"4455","DOI":"10.1210\/jc.2014-2702","volume":"99","author":"S Pedicelli","year":"2014","unstructured":"Pedicelli, S., et al. (2014). Routine screening by brain magnetic resonance imaging is not indicated in every Girl with onset of puberty between the ages of 6 and 8 years. J. Clin. Endocrinol. Metab., 99(12), 4455\u20134461.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"4461_CR3","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/S2213-8587(15)00418-0","volume":"4","author":"AP Abreu","year":"2016","unstructured":"Abreu, A. P., & Kaiser, U. B. (2016). Pubertal development and regulation. Lancet Diabetes Endocrinol., 4(3), 254\u2013264.","journal-title":"Lancet Diabetes Endocrinol."},{"key":"4461_CR4","unstructured":"A. Papathanasiou, C. Hadjiathanasiou, Precocious puberty. Pediatr Endocrinol Rev, 2006. 3 Suppl 1: pp. 182-7"},{"issue":"235","key":"4461_CR5","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1136\/adc.44.235.291","volume":"44","author":"WA Marshall","year":"1969","unstructured":"Marshall, W. A., & Tanner, J. M. (1969). Variations in pattern of pubertal changes in girls. Arch. Dis. Child., 44(235), 291\u2013303.","journal-title":"Arch. Dis. Child."},{"key":"4461_CR6","doi-asserted-by":"publisher","first-page":"1107911","DOI":"10.3389\/fendo.2022.1107911","volume":"13","author":"S Prosperi","year":"2022","unstructured":"Prosperi, S., & Chiarelli, F. (2022). Early and precocious puberty during the COVID-19 pandemic. Front. Endocrinol. (Lausanne), 13, 1107911.","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"4 Pt 1","key":"4461_CR7","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1542\/peds.104.4.936","volume":"104","author":"PB Kaplowitz","year":"1999","unstructured":"Kaplowitz, P. B., & Oberfield, S. E. (1999). Reexamination of the age limit for defining when puberty is precocious in girls in the united states: implications for evaluation and treatment. Drug and therapeutics and executive committees of the Lawson Wilkins pediatric endocrine society. Pediatrics, 104(4 Pt 1), 936\u2013941.","journal-title":"Pediatrics"},{"issue":"3","key":"4461_CR8","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1542\/peds.106.3.622","volume":"106","author":"RL Rosenfield","year":"2000","unstructured":"Rosenfield, R. L., et al. (2000). Current age of onset of puberty. Pediatrics, 106(3), 622\u2013623.","journal-title":"Pediatrics"},{"issue":"3","key":"4461_CR9","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1210\/jc.2006-2012","volume":"92","author":"RL Rosenfield","year":"2007","unstructured":"Rosenfield, R. L. (2007). Clinical review: identifying children at risk for polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 92(3), 787\u2013796.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"4461_CR10","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1093\/humrep\/dew218","volume":"31","author":"G Bozdag","year":"2016","unstructured":"Bozdag, G., et al. (2016). The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum. Reprod., 31(12), 2841\u20132855.","journal-title":"Hum. Reprod."},{"issue":"5","key":"4461_CR11","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1210\/er.2015-1104","volume":"37","author":"RL Rosenfield","year":"2016","unstructured":"Rosenfield, R. L., & Ehrmann, D. A. (2016). The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr. Rev., 37(5), 467\u2013520.","journal-title":"Endocr. Rev."},{"issue":"3","key":"4461_CR12","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1007\/s43032-021-00516-3","volume":"29","author":"MC Eiras","year":"2022","unstructured":"Eiras, M. C., et al. (2022). Polycystic ovary syndrome: the epigenetics behind the disease. Reprod. Sci., 29(3), 680\u2013694.","journal-title":"Reprod. Sci."},{"issue":"6","key":"4461_CR13","first-page":"1599","volume":"76","author":"L Ibanez","year":"1993","unstructured":"Ibanez, L., et al. (1993). Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism. J. Clin. Endocrinol. Metab., 76(6), 1599\u20131603.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"4461_CR14","first-page":"671","volume":"21","author":"L Ibanez","year":"2000","unstructured":"Ibanez, L., et al. (2000). Premature adrenarche\u2013normal variant or forerunner of adult disease?. Endocr. Rev., 21(6), 671\u2013696.","journal-title":"Endocr. Rev."},{"key":"4461_CR15","doi-asserted-by":"publisher","first-page":"l6597","DOI":"10.1136\/bmj.l6597","volume":"368","author":"SH Bradley","year":"2020","unstructured":"Bradley, S. H., et al. (2020). Precocious Puberty BMJ, 368, l6597.","journal-title":"Precocious Puberty BMJ"},{"issue":"4","key":"4461_CR16","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.beem.2018.05.008","volume":"32","author":"RS Aguirre","year":"2018","unstructured":"Aguirre, R. S., & Eugster, E. A. (2018). Central precocious puberty: from genetics to treatment. Best Pract. Res. Clin. Endocrinol. Metab., 32(4), 343\u2013354.","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"9","key":"4461_CR17","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.1210\/jc.2010-1025","volume":"95","author":"L Soriano-Guillen","year":"2010","unstructured":"Soriano-Guillen, L., et al. (2010). Central precocious puberty in children living in spain: incidence, prevalence, and influence of adoption and immigration. J. Clin. Endocrinol. Metab., 95(9), 4305\u20134313.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"4461_CR18","doi-asserted-by":"publisher","first-page":"e0141844","DOI":"10.1371\/journal.pone.0141844","volume":"10","author":"SH Kim","year":"2015","unstructured":"Kim, S. H., et al. (2015). A significant increase in the incidence of central precocious puberty among Korean girls from 2004 to 2010. PLoS One, 10(11), e0141844.","journal-title":"PLoS One"},{"issue":"3","key":"4461_CR19","doi-asserted-by":"publisher","first-page":"302","DOI":"10.4274\/jcrpe.galenos.2022.2022-12-11","volume":"14","author":"KY Acinikli","year":"2022","unstructured":"Acinikli, K. Y., et al. (2022). Has the frequency of precocious puberty and rapidly progressive early puberty increased in girls during the COVID-19 pandemic?. J. Clin. Res. Pediatr. Endocrinol., 14(3), 302\u2013307.","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"issue":"6","key":"4461_CR20","first-page":"517","volume":"36","author":"M Baby","year":"2023","unstructured":"Baby, M., Ilkowitz, J., Cheema, P., & Brar (2023). Impacts of the COVID-19 pandemic on the diagnosis of idiopathic central precocious puberty in pediatric females in new York City. J. Pediatr. Endocrinol. Metab., 36(6), 517\u2013522.","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"2","key":"4461_CR21","doi-asserted-by":"publisher","first-page":"G43","DOI":"10.1093\/ejendo\/lvad096","volume":"189","author":"HJ Teede","year":"2023","unstructured":"Teede, H. J., et al. (2023). Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Eur. J. Endocrinol., 189(2), G43\u2013G64.","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"4461_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0015-0282(00)01662-9","volume":"75","author":"MD Kahsar-Miller","year":"2001","unstructured":"Kahsar-Miller, M. D., et al. (2001). Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. Fertil. Steril., 75(1), 53\u201358.","journal-title":"Fertil. Steril."},{"issue":"1","key":"4461_CR23","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1210\/jc.2007-1834","volume":"93","author":"BO Yildiz","year":"2008","unstructured":"Yildiz, B. O., Knochenhauer, E. S., & Azziz, R. (2008). Impact of obesity on the risk for polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 93(1), 162\u2013168.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"4461_CR24","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1210\/jc.2006-0108","volume":"91","author":"E Codner","year":"2006","unstructured":"Codner, E., et al. (2006). Diagnostic criteria for polycystic ovary syndrome and ovarian morphology in women with type 1 diabetes mellitus. J. Clin. Endocrinol. Metab., 91(6), 2250\u20132256.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"4461_CR25","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.2337\/diacare.24.6.1050","volume":"24","author":"HR Peppard","year":"2001","unstructured":"Peppard, H. R., et al. (2001). Prevalence of polycystic ovary syndrome among premenopausal women with type 2 diabetes. Diabetes Care, 24(6), 1050\u20131052.","journal-title":"Diabetes Care"},{"issue":"4","key":"4461_CR26","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1210\/jcem.83.4.4707","volume":"83","author":"J Holte","year":"1998","unstructured":"Holte, J., et al. (1998). High prevalence of polycystic ovaries and associated clinical, endocrine, and metabolic features in women with previous gestational diabetes mellitus. J. Clin. Endocrinol. Metab., 83(4), 1143\u20131150.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1\u20132","key":"4461_CR27","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.eplepsyres.2011.07.006","volume":"97","author":"X Hu","year":"2011","unstructured":"Hu, X., et al. (2011). A meta-analysis of polycystic ovary syndrome in women taking valproate for epilepsy. Epilepsy Res., 97(1\u20132), 73\u201382.","journal-title":"Epilepsy Res."},{"issue":"7","key":"4461_CR28","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/0002-9378(84)90118-2","volume":"149","author":"AW Root","year":"1984","unstructured":"Root, A. W., & Moshang, Jr, T. (1984). Evolution of the hyperandrogenism-polycystic ovary syndrome from isosexual precocious puberty: report of two cases. Am. J. Obstet. Gynecol., 149(7), 763\u2013767.","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"4461_CR29","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1365-2265.1995.tb01853.x","volume":"42","author":"NA Bridges","year":"1995","unstructured":"Bridges, N. A., et al. (1995). Ovaries in sexual precocity. Clin. Endocrinol. (Oxf), 42(2), 135\u2013140.","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"3","key":"4461_CR30","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1159\/000182288","volume":"37","author":"M Cisternino","year":"1992","unstructured":"Cisternino, M., et al. (1992). Final height attainment and gonadal function in girls with precocious puberty treated with cyproterone acetate. Horm. Res., 37(3), 86\u201390.","journal-title":"Horm. Res."},{"issue":"13","key":"4461_CR31","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1056\/NEJM199509283331307","volume":"333","author":"S Franks","year":"1995","unstructured":"Franks, S. (1995). Polycystic ovary syndrome. N Engl. J. Med., 333(13), 853\u2013861.","journal-title":"N Engl. J. Med."},{"issue":"9","key":"4461_CR32","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s001250051030","volume":"41","author":"L Ibanez","year":"1998","unstructured":"Ibanez, L., et al. (1998). Hyperinsulinaemia, dyslipaemia and cardiovascular risk in girls with a history of premature pubarche. Diabetologia, 41(9), 1057\u20131063.","journal-title":"Diabetologia"},{"issue":"4","key":"4461_CR33","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1530\/eje.0.1330403","volume":"133","author":"L Lazar","year":"1995","unstructured":"Lazar, L., et al. (1995). Early polycystic ovary-like syndrome in girls with central precocious puberty and exaggerated adrenal response. Eur. J. Endocrinol., 133(4), 403\u2013406.","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"4461_CR34","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1530\/eje.0.1330407","volume":"133","author":"L Lazar","year":"1995","unstructured":"Lazar, L., et al. (1995). High prevalence of abnormal adrenal response in girls with central precocious puberty at early pubertal stages. Eur. J. Endocrinol., 133(4), 407\u2013411.","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"4461_CR35","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.fertnstert.2008.11.016","volume":"93","author":"R Franceschi","year":"2010","unstructured":"Franceschi, R., et al. (2010). Prevalence of polycystic ovary syndrome in young women who had idiopathic central precocious puberty. Fertil. Steril., 93(4), 1185\u20131191.","journal-title":"Fertil. Steril."},{"issue":"3","key":"4461_CR36","doi-asserted-by":"publisher","first-page":"R79","DOI":"10.1530\/EJE-15-0590","volume":"174","author":"F Guaraldi","year":"2016","unstructured":"Guaraldi, F., et al. (2016). MANAGEMENT OF ENDOCRINE DISEASE: Long-term outcomes of the treatment of central precocious puberty. Eur. J. Endocrinol., 174(3), R79\u201387.","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"4461_CR37","first-page":"345","volume":"90","author":"V De Sanctis","year":"2019","unstructured":"De Sanctis, V., et al. (2019). Long-term effects and significant adverse drug reactions (ADRs) associated with the use of Gonadotropin-Releasing hormone analogs (GnRHa) for central precocious puberty: a brief review of literature. Acta Biomed., 90(3), 345\u2013359.","journal-title":"Acta Biomed."},{"issue":"1","key":"4461_CR38","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40842-021-00129-4","volume":"7","author":"G Karavani","year":"2021","unstructured":"Karavani, G., et al. (2021). Gonadotropin releasing hormone analogue treatment of central precocious puberty is not associated with altered prevalence of polycystic ovary syndrome: a single center cohort study. Clin. Diabetes Endocrinol., 7(1), 14.","journal-title":"Clin. Diabetes Endocrinol."},{"issue":"2","key":"4461_CR39","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1159\/000531264","volume":"97","author":"AJ Arcari","year":"2024","unstructured":"Arcari, A. J., et al. (2024). Prevalence of polycystic ovarian syndrome in girls with a history of idiopathic central precocious puberty. Horm. Res. Paediatr., 97(2), 134\u2013139.","journal-title":"Horm. Res. Paediatr."},{"key":"4461_CR40","doi-asserted-by":"publisher","first-page":"1314752","DOI":"10.3389\/fendo.2024.1314752","volume":"15","author":"D Orszulak","year":"2024","unstructured":"Orszulak, D., et al. (2024). The effect of gonadoliberin analog treatment in precocious puberty on polycystic ovarian syndrome prevalence in adulthood. Front. Endocrinol. (Lausanne), 15, 1314752.","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"4","key":"4461_CR41","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/cen.12319","volume":"80","author":"L Lazar","year":"2014","unstructured":"Lazar, L., et al. (2014). Treated and untreated women with idiopathic precocious puberty: long-term follow-up and reproductive outcome between the third and fifth decades. Clin. Endocrinol. (Oxf), 80(4), 570\u2013576.","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"12","key":"4461_CR42","first-page":"4583","volume":"84","author":"S Heger","year":"1999","unstructured":"Heger, S., Partsch, C. J., & Sippell, W. G. (1999). Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function. J. Clin. Endocrinol. Metab., 84(12), 4583\u20134590.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"4461_CR43","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1210\/jc.2009-0793","volume":"95","author":"MA Magiakou","year":"2010","unstructured":"Magiakou, M. A., et al. (2010). The efficacy and safety of gonadotropin-releasing hormone analog treatment in childhood and adolescence: a single center, long-term follow-up study. J. Clin. Endocrinol. Metab., 95(1), 109\u2013117.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"4461_CR44","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1111\/cen.14410","volume":"94","author":"X Luo","year":"2021","unstructured":"Luo, X., et al. (2021). Long-term efficacy and safety of gonadotropin-releasing hormone analog treatment in children with idiopathic central precocious puberty: A systematic review and meta-analysis. Clin. Endocrinol. (Oxf), 94(5), 786\u2013796.","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"4","key":"4461_CR45","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.jpeds.2006.05.026","volume":"149","author":"A Cassio","year":"2006","unstructured":"Cassio, A., et al. (2006). Reproductive outcome in patients treated and not treated for idiopathic early puberty: long-term results of a randomized trial in adults. J. Pediatr., 149(4), 532\u2013536.","journal-title":"J. Pediatr."},{"issue":"1","key":"4461_CR46","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1530\/EJE-09-1102","volume":"163","author":"V Chiavaroli","year":"2010","unstructured":"Chiavaroli, V., et al. (2010). GNRH analog therapy in girls with early puberty is associated with the achievement of predicted final height but also with increased risk of polycystic ovary syndrome. Eur. J. Endocrinol., 163(1), 55\u201362.","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"4461_CR47","doi-asserted-by":"publisher","first-page":"R107","DOI":"10.1530\/EJE-20-0103","volume":"183","author":"SA Roberts","year":"2020","unstructured":"Roberts, S. A., & Kaiser, U. B. (2020). GENETICS IN ENDOCRINOLOGY: genetic etiologies of central precocious puberty and the role of imprinted genes. Eur. J. Endocrinol., 183(4), R107\u2013R117.","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"4461_CR48","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/j.1365-3016.2010.01183.x","volume":"25","author":"DH Morris","year":"2011","unstructured":"Morris, D. H., et al. (2011). Familial concordance for age at menarche: analyses from the breakthrough generations study. Paediatr. Perinat. Epidemiol., 25(3), 306\u2013311.","journal-title":"Paediatr. Perinat. Epidemiol."},{"issue":"2","key":"4461_CR49","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/03014468300006301","volume":"10","author":"JC Sharma","year":"1983","unstructured":"Sharma, J. C. (1983). The genetic contribution to pubertal growth and development studied by longitudinal growth data on twins. Ann. Hum. Biol., 10(2), 163\u2013171.","journal-title":"Ann. Hum. Biol."},{"issue":"6","key":"4461_CR50","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1210\/jc.2005-1494","volume":"91","author":"JM Vink","year":"2006","unstructured":"Vink, J. M., et al. (2006). Heritability of polycystic ovary syndrome in a Dutch twin-family study. J. Clin. Endocrinol. Metab., 91(6), 2100\u20132104.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"4461_CR51","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1210\/jc.2008-2836","volume":"94","author":"T Sir-Petermann","year":"2009","unstructured":"Sir-Petermann, T., et al. (2009). Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 94(6), 1923\u20131930.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"4461_CR52","doi-asserted-by":"publisher","first-page":"3396","DOI":"10.1210\/jc.2008-0369","volume":"93","author":"S Franks","year":"2008","unstructured":"Franks, S., et al. (2008). Ovarian morphology is a marker of heritable biochemical traits in sisters with polycystic ovaries. J. Clin. Endocrinol. Metab., 93(9), 3396\u20133402.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"25","key":"4461_CR53","doi-asserted-by":"publisher","first-page":"14956","DOI":"10.1073\/pnas.95.25.14956","volume":"95","author":"RS Legro","year":"1998","unstructured":"Legro, R. S., et al. (1998). Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc. Natl. Acad. Sci. U S A, 95(25), 14956\u201314960.","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"4461_CR54","doi-asserted-by":"publisher","first-page":"111094","DOI":"10.1016\/j.mce.2020.111094","volume":"520","author":"M Spaziani","year":"2021","unstructured":"Spaziani, M., et al. (2021). Hypothalamo-Pituitary axis and puberty. Mol. Cell. Endocrinol., 520, 111094.","journal-title":"Mol. Cell. Endocrinol."},{"issue":"6","key":"4461_CR55","first-page":"278","volume":"68","author":"ME Escobar","year":"2007","unstructured":"Escobar, M. E., et al. (2007). Acceleration of luteinizing hormone pulse frequency in adolescent girls with a history of central precocious puberty with versus without hyperandrogenism. Horm. Res., 68(6), 278\u2013285.","journal-title":"Horm. Res."},{"issue":"5","key":"4461_CR56","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1210\/jc.2009-2421","volume":"95","author":"LG Silveira","year":"2010","unstructured":"Silveira, L. G., et al. (2010). Mutations of the KISS1 gene in disorders of puberty. J. Clin. Endocrinol. Metab., 95(5), 2276\u20132280.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"4461_CR57","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJMoa073443","volume":"358","author":"MG Teles","year":"2008","unstructured":"Teles, M. G., et al. (2008). A GPR54-activating mutation in a patient with central precocious puberty. N Engl. J. Med., 358(7), 709\u2013715.","journal-title":"N Engl. J. Med."},{"issue":"1","key":"4461_CR58","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1159\/000357734","volume":"99","author":"P Grachev","year":"2014","unstructured":"Grachev, P., Millar, R. P., & O\u2019Byrne, K. T. (2014). The role of neurokinin B signalling in reproductive neuroendocrinology. Neuroendocrinology, 99(1), 7\u201317.","journal-title":"Neuroendocrinology"},{"issue":"1\u20132","key":"4461_CR59","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.mce.2010.02.020","volume":"324","author":"AK Topaloglu","year":"2010","unstructured":"Topaloglu, A. K. (2010). Neurokinin B signaling in puberty: human and animal studies. Mol. Cell. Endocrinol., 324(1\u20132), 64\u201369.","journal-title":"Mol. Cell. Endocrinol."},{"issue":"5","key":"4461_CR60","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1210\/jc.2014-4462","volume":"100","author":"CP Hagen","year":"2015","unstructured":"Hagen, C. P., et al. (2015). Circulating MKRN3 levels decline prior to pubertal onset and through puberty: a longitudinal study of healthy girls. J. Clin. Endocrinol. Metab., 100(5), 1920\u20131926.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"26","key":"4461_CR61","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1056\/NEJMoa1302160","volume":"368","author":"AP Abreu","year":"2013","unstructured":"Abreu, A. P., et al. (2013). Central precocious puberty caused by mutations in the imprinted gene MKRN3. N Engl. J. Med., 368(26), 2467\u20132475.","journal-title":"N Engl. J. Med."},{"issue":"5","key":"4461_CR62","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1210\/js.2019-00041","volume":"3","author":"LP Valadares","year":"2019","unstructured":"Valadares, L. P., et al. (2019). MKRN3 mutations in central precocious puberty: A systematic review and Meta-Analysis. J. Endocr. Soc., 3(5), 979\u2013995.","journal-title":"J. Endocr. Soc."},{"issue":"3","key":"4461_CR63","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1093\/ejendo\/lvad129","volume":"189","author":"L Montenegro","year":"2023","unstructured":"Montenegro, L., et al. (2023). Familial central precocious puberty due to DLK1 deficiency: novel genetic findings and relevance of serum DLK1 levels. Eur. J. Endocrinol., 189(3), 422\u2013428.","journal-title":"Eur. J. Endocrinol."},{"issue":"6","key":"4461_CR64","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/ng.3841","volume":"49","author":"FR Day","year":"2017","unstructured":"Day, F. R., et al. (2017). Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk. Nat. Genet., 49(6), 834\u2013841.","journal-title":"Nat. Genet."},{"issue":"4","key":"4461_CR65","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/09674845.2020.1864109","volume":"78","author":"M Farsimadan","year":"2021","unstructured":"Farsimadan, M., et al. (2021). Association analysis of KISS1 polymorphisms and haplotypes with polycystic ovary syndrome. Br. J. Biomed. Sci., 78(4), 201\u2013205.","journal-title":"Br. J. Biomed. Sci."},{"issue":"1","key":"4461_CR66","doi-asserted-by":"publisher","first-page":"292","DOI":"10.2478\/enr-2023-0032","volume":"57","author":"A Aasif","year":"2023","unstructured":"Aasif, A., et al. (2023). The role of Kisspeptin in the pathogenesis of a polycystic ovary syndrome. Endocr. Regul., 57(1), 292\u2013303.","journal-title":"Endocr. Regul."},{"issue":"6","key":"4461_CR67","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1111\/jog.14767","volume":"47","author":"J Liu","year":"2021","unstructured":"Liu, J., et al. (2021). Serum Kisspeptin levels in polycystic ovary syndrome: A meta-analysis. J. Obstet. Gynaecol. Res., 47(6), 2157\u20132165.","journal-title":"J. Obstet. Gynaecol. Res."},{"issue":"3","key":"4461_CR68","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1080\/09513590.2018.1519792","volume":"35","author":"C Kaya","year":"2019","unstructured":"Kaya, C., et al. (2019). Serum Kisspeptin levels in unexplained infertility, polycystic ovary syndrome, and male factor infertility. Gynecol. Endocrinol., 35(3), 228\u2013232.","journal-title":"Gynecol. Endocrinol."},{"issue":"4","key":"4461_CR69","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/j.1365-2265.2009.03575.x","volume":"71","author":"L de Vries","year":"2009","unstructured":"de Vries, L., et al. (2009). Kisspeptin serum levels in girls with central precocious puberty. Clin. Endocrinol. (Oxf), 71(4), 524\u2013528.","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"7","key":"4461_CR70","doi-asserted-by":"publisher","first-page":"927","DOI":"10.3346\/jkms.2011.26.7.927","volume":"26","author":"YJ Rhie","year":"2011","unstructured":"Rhie, Y. J., et al. (2011). Serum Kisspeptin levels in Korean girls with central precocious puberty. J. Korean Med. Sci., 26(7), 927\u2013931.","journal-title":"J. Korean Med. Sci."},{"issue":"9","key":"4461_CR71","doi-asserted-by":"publisher","first-page":"718","DOI":"10.3109\/09513590.2016.1161019","volume":"32","author":"O Emekci Ozay","year":"2016","unstructured":"Emekci Ozay, O., et al. (2016). Role of Kisspeptin in polycystic ovary syndrome (PCOS). Gynecol. Endocrinol., 32(9), 718\u2013722.","journal-title":"Gynecol. Endocrinol."},{"issue":"1","key":"4461_CR72","doi-asserted-by":"publisher","first-page":"2215869","DOI":"10.1080\/09513590.2023.2215869","volume":"39","author":"M Gao","year":"2023","unstructured":"Gao, M., et al. (2023). Correlation between Kisspeptin and biochemical markers in obese and non-obese women with polycystic ovary syndrome. Gynecol. Endocrinol., 39(1), 2215869.","journal-title":"Gynecol. Endocrinol."},{"key":"4461_CR73","doi-asserted-by":"publisher","first-page":"107960","DOI":"10.1016\/j.pharmthera.2021.107960","volume":"230","author":"K Skorupskaite","year":"2022","unstructured":"Skorupskaite, K., & Anderson, R. A. (2022). Hypothalamic neurokinin signalling and its application in reproductive medicine. Pharmacol. Ther., 230, 107960.","journal-title":"Pharmacol. Ther."},{"issue":"11","key":"4461_CR74","doi-asserted-by":"publisher","first-page":"4313","DOI":"10.1210\/jc.2016-1202","volume":"101","author":"JT George","year":"2016","unstructured":"George, J. T., et al. (2016). Neurokinin B receptor antagonism in women with polycystic ovary syndrome: A Randomized, Placebo-Controlled trial. J. Clin. Endocrinol. Metabolism, 101(11), 4313\u20134321.","journal-title":"J. Clin. Endocrinol. Metabolism"},{"issue":"9","key":"4461_CR75","doi-asserted-by":"publisher","first-page":"e3519","DOI":"10.1210\/clinem\/dgab320","volume":"106","author":"GL Fraser","year":"2021","unstructured":"Fraser, G. L., et al. (2021). Randomized controlled trial of neurokinin 3 receptor antagonist fezolinetant for treatment of polycystic ovary syndrome. J. Clin. Endocrinol. Metabolism, 106(9), e3519\u2013e3532.","journal-title":"J. Clin. Endocrinol. Metabolism"},{"issue":"7","key":"4461_CR76","first-page":"2248","volume":"82","author":"AE Taylor","year":"1997","unstructured":"Taylor, A. E., et al. (1997). Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 82(7), 2248\u20132256.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"4461_CR77","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1210\/jc.2008-2606","volume":"94","author":"SK Blank","year":"2009","unstructured":"Blank, S. K., et al. (2009). Modulation of gonadotropin-releasing hormone pulse generator sensitivity to progesterone Inhibition in hyperandrogenic adolescent girls\u2013implications for regulation of pubertal maturation. J. Clin. Endocrinol. Metab., 94(7), 2360\u20132366.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4461_CR78","doi-asserted-by":"publisher","first-page":"7502","DOI":"10.1038\/ncomms8502","volume":"6","author":"MG Hayes","year":"2015","unstructured":"Hayes, M. G., et al. (2015). Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations. Nat. Commun., 6, 7502.","journal-title":"Nat. Commun."},{"issue":"1","key":"4461_CR79","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1365-2265.2012.04372.x","volume":"77","author":"A Capalbo","year":"2012","unstructured":"Capalbo, A., et al. (2012). The 312\u00a0N variant of the luteinizing hormone\/choriogonadotropin receptor gene (LHCGR) confers up to 2.7-fold increased risk of polycystic ovary syndrome in a Sardinian population. Clin. Endocrinol. (Oxf), 77(1), 113\u2013119.","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"4461_CR80","unstructured":"Z.J. Chen et al., Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet, 2011. 43(1): pp. 55\u2009\u2013\u20099"},{"issue":"12","key":"4461_CR81","doi-asserted-by":"publisher","first-page":"e1007813","DOI":"10.1371\/journal.pgen.1007813","volume":"14","author":"F Day","year":"2018","unstructured":"Day, F., et al. (2018). Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria. PLoS Genet., 14(12), e1007813.","journal-title":"PLoS Genet."},{"issue":"9","key":"4461_CR82","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/ng.2384","volume":"44","author":"Y Shi","year":"2012","unstructured":"Shi, Y., et al. (2012). Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nat. Genet., 44(9), 1020\u20131025.","journal-title":"Nat. Genet."},{"issue":"1","key":"4461_CR83","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1210\/jc.2005-2012","volume":"91","author":"K Qin","year":"2006","unstructured":"Qin, K., et al. (2006). Identification of a functional polymorphism of the human type 5 17beta-hydroxysteroid dehydrogenase gene associated with polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 91(1), 270\u2013276.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"4461_CR84","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1136\/jmedgenet-2011-100727","volume":"49","author":"T Li","year":"2012","unstructured":"Li, T., et al. (2012). Identification of YAP1 as a novel susceptibility gene for polycystic ovary syndrome. J. Med. Genet., 49(4), 254\u2013257.","journal-title":"J. Med. Genet."},{"issue":"4","key":"4461_CR85","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1093\/molehr\/gal120","volume":"13","author":"MR Jones","year":"2007","unstructured":"Jones, M. R., et al. (2007). Polymorphism of the follistatin gene in polycystic ovary syndrome. Mol. Hum. Reprod., 13(4), 237\u2013241.","journal-title":"Mol. Hum. Reprod."},{"issue":"1","key":"4461_CR86","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12864-024-09990-w","volume":"25","author":"K Burns","year":"2024","unstructured":"Burns, K., et al. (2024). Body mass index stratified meta-analysis of genome-wide association studies of polycystic ovary syndrome in women of European ancestry. BMC Genom., 25(1), 208.","journal-title":"BMC Genom."},{"issue":"3","key":"4461_CR87","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1055\/s-0034-1371089","volume":"32","author":"CK Welt","year":"2014","unstructured":"Welt, C. K., & Duran, J. M. (2014). Genetics of polycystic ovary syndrome. Semin Reprod. Med., 32(3), 177\u2013182.","journal-title":"Semin Reprod. Med."},{"issue":"8","key":"4461_CR88","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s40618-017-0627-9","volume":"40","author":"S Leka-Emiri","year":"2017","unstructured":"Leka-Emiri, S., Chrousos, G. P., & Kanaka-Gantenbein, C. (2017). The mystery of puberty initiation: genetics and epigenetics of idiopathic central precocious puberty (ICPP). J. Endocrinol. Invest., 40(8), 789\u2013802.","journal-title":"J. Endocrinol. Invest."},{"issue":"3","key":"4461_CR89","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1159\/000336325","volume":"77","author":"K Sorensen","year":"2012","unstructured":"Sorensen, K., et al. (2012). Recent secular trends in pubertal timing: implications for evaluation and diagnosis of precocious puberty. Horm. Res. Paediatr., 77(3), 137\u2013145.","journal-title":"Horm. Res. Paediatr."},{"issue":"3","key":"4461_CR90","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1055\/s-0034-1371087","volume":"32","author":"DA Dumesic","year":"2014","unstructured":"Dumesic, D. A., et al. (2014). Intrauterine environment and polycystic ovary syndrome. Semin Reprod. Med., 32(3), 159\u2013165.","journal-title":"Semin Reprod. Med."},{"issue":"4","key":"4461_CR91","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1093\/humupd\/dmx013","volume":"23","author":"P Filippou","year":"2017","unstructured":"Filippou, P., & Homburg, R. (2017). Is foetal hyperexposure to androgens a cause of PCOS?. Hum. Reprod. Update, 23(4), 421\u2013432.","journal-title":"Hum. Reprod. Update"},{"issue":"11","key":"4461_CR92","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1080\/15592294.2020.1754674","volume":"15","author":"B Echiburu","year":"2020","unstructured":"Echiburu, B., et al. (2020). DNA methylation in promoter regions of genes involved in the reproductive and metabolic function of children born to women with PCOS. Epigenetics, 15(11), 1178\u20131194.","journal-title":"Epigenetics"},{"issue":"1","key":"4461_CR93","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13148-018-0581-1","volume":"10","author":"DS Bessa","year":"2018","unstructured":"Bessa, D. S., et al. (2018). Methylome profiling of healthy and central precocious puberty girls. Clin. Epigenetics, 10(1), 146.","journal-title":"Clin. Epigenetics"},{"key":"4461_CR94","doi-asserted-by":"crossref","unstructured":"H. Wright et al., Polycomb represses a gene network controlling puberty via modulation of histone demethylase Kdm6b expression. Sci Rep, 2021. 11(1): p. 1996","DOI":"10.1038\/s41598-021-81689-4"},{"issue":"9","key":"4461_CR95","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/BF03350781","volume":"21","author":"L Ibanez","year":"1998","unstructured":"Ibanez, L., de Zegher, F., & Potau, N. (1998). Premature pubarche, ovarian hyperandrogenism, hyperinsulinism and the polycystic ovary syndrome: from a complex constellation to a simple sequence of prenatal onset. J. Endocrinol. Invest., 21(9), 558\u2013566.","journal-title":"J. Endocrinol. Invest."},{"issue":"5","key":"4461_CR96","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.molmed.2023.02.006","volume":"29","author":"L Ibanez","year":"2023","unstructured":"Ibanez, L., & de Zegher, F. (2023). Adolescent PCOS: a postpubertal central obesity syndrome. Trends Mol. Med., 29(5), 354\u2013363.","journal-title":"Trends Mol. Med."},{"issue":"6","key":"4461_CR97","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1210\/jc.2005-2778","volume":"91","author":"L Ibanez","year":"2006","unstructured":"Ibanez, L., et al. (2006). Early development of adiposity and insulin resistance after catch-up weight gain in small-for-gestational-age children. J. Clin. Endocrinol. Metab., 91(6), 2153\u20132158.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"4461_CR98","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1203\/00006450-199511000-00017","volume":"38","author":"J Karlberg","year":"1995","unstructured":"Karlberg, J., & Albertsson-Wikland, K. (1995). Growth in full-term small-for-gestational-age infants: from birth to final height. Pediatr. Res., 38(5), 733\u2013739.","journal-title":"Pediatr. Res."},{"issue":"Suppl 5","key":"4461_CR99","first-page":"1243","volume":"15","author":"J Karlberg","year":"2002","unstructured":"Karlberg, J., et al. (2002). Early spontaneous catch-up growth. J. Pediatr. Endocrinol. Metab., 15(Suppl 5), 1243\u20131255.","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"9","key":"4461_CR100","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.tem.2009.06.003","volume":"20","author":"F de Zegher","year":"2009","unstructured":"de Zegher, F., Lopez-Bermejo, A., & Ibanez, L. (2009). Adipose tissue expandability and the early origins of PCOS. Trends Endocrinol. Metab., 20(9), 418\u2013423.","journal-title":"Trends Endocrinol. Metab."},{"issue":"2","key":"4461_CR101","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00431-003-1358-9","volume":"163","author":"ML Charkaluk","year":"2004","unstructured":"Charkaluk, M. L., Trivin, C., & Brauner, R. (2004). Premature pubarche as an indicator of how body weight influences the onset of adrenarche. Eur. J. Pediatr., 163(2), 89\u201393.","journal-title":"Eur. J. Pediatr."},{"issue":"6","key":"4461_CR102","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1210\/jc.2003-031848","volume":"89","author":"KK Ong","year":"2004","unstructured":"Ong, K. K., et al. (2004). Opposing influences of prenatal and postnatal weight gain on adrenarche in normal boys and girls. J. Clin. Endocrinol. Metab., 89(6), 2647\u20132651.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"4461_CR103","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1172\/JCI118126","volume":"96","author":"A Dunaif","year":"1995","unstructured":"Dunaif, A., et al. (1995). Excessive insulin receptor Serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome. J. Clin. Invest., 96(2), 801\u2013810.","journal-title":"J. Clin. Invest."},{"issue":"1","key":"4461_CR104","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13048-022-01091-0","volume":"16","author":"H Zhao","year":"2023","unstructured":"Zhao, H., et al. (2023). Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment. J. Ovarian Res., 16(1), 9.","journal-title":"J. Ovarian Res."},{"issue":"6","key":"4461_CR105","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1093\/ije\/31.6.1235","volume":"31","author":"DJ Barker","year":"2002","unstructured":"Barker, D. J., et al. (2002). Fetal origins of adult disease: strength of effects and biological basis. Int. J. Epidemiol., 31(6), 1235\u20131239.","journal-title":"Int. J. Epidemiol."},{"issue":"2","key":"4461_CR106","first-page":"91","volume":"15","author":"P Ghirri","year":"2001","unstructured":"Ghirri, P., et al. (2001). Adrenarche, pubertal development, age at menarche and final height of full-term, born small for gestational age (SGA) girls. Gynecol. Endocrinol., 15(2), 91\u201397.","journal-title":"Gynecol. Endocrinol."},{"issue":"11","key":"4461_CR107","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1515\/JPEM.2004.17.11.1497","volume":"17","author":"MA Veening","year":"2004","unstructured":"Veening, M. A., et al. (2004). Pubertal development in children born small for gestational age. J. Pediatr. Endocrinol. Metab., 17(11), 1497\u20131505.","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"9085","key":"4461_CR108","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/S0140-6736(97)06062-5","volume":"350","author":"JL Cresswell","year":"1997","unstructured":"Cresswell, J. L., et al. (1997). Fetal growth, length of gestation, and polycystic ovaries in adult life. Lancet, 350(9085), 1131\u20131135.","journal-title":"Lancet"},{"issue":"6","key":"4461_CR109","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/sj.ijo.0802301","volume":"27","author":"J Laitinen","year":"2003","unstructured":"Laitinen, J., et al. (2003). Body size from birth to adulthood as a predictor of self-reported polycystic ovary syndrome symptoms. Int. J. Obes. Relat. Metab. Disord, 27(6), 710\u2013715.","journal-title":"Int. J. Obes. Relat. Metab. Disord"},{"issue":"11","key":"4461_CR110","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1210\/jcem.84.11.6106","volume":"84","author":"D Jaquet","year":"1999","unstructured":"Jaquet, D., et al. (1999). Intrauterine growth retardation predisposes to insulin resistance but not to hyperandrogenism in young women. J. Clin. Endocrinol. Metab., 84(11), 3945\u20133949.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"4461_CR111","doi-asserted-by":"publisher","first-page":"3558","DOI":"10.1210\/jcem.83.10.5205","volume":"83","author":"L Ibanez","year":"1998","unstructured":"Ibanez, L., et al. (1998). Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth. J. Clin. Endocrinol. Metab., 83(10), 3558\u20133562.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"4461_CR112","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1530\/EJE-20-1462","volume":"185","author":"M Paalanne","year":"2021","unstructured":"Paalanne, M., et al. (2021). Clinical and biochemical signs of polycystic ovary syndrome in young women born preterm. Eur. J. Endocrinol., 185(2), 279\u2013288.","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"4461_CR113","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1159\/000515294","volume":"14","author":"J Aarestrup","year":"2021","unstructured":"Aarestrup, J., et al. (2021). Birthweight, childhood body mass Index, height and Growth, and risk of polycystic ovary syndrome. Obes. Facts, 14(3), 283\u2013290.","journal-title":"Obes. Facts"},{"issue":"8","key":"4461_CR114","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1093\/humrep\/deq162","volume":"25","author":"AS Melo","year":"2010","unstructured":"Melo, A. S., et al. (2010). High prevalence of polycystic ovary syndrome in women born small for gestational age. Hum. Reprod., 25(8), 2124\u20132131.","journal-title":"Hum. Reprod."},{"issue":"3","key":"4461_CR115","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.fertnstert.2012.11.004","volume":"99","author":"H Mumm","year":"2013","unstructured":"Mumm, H., et al. (2013). Birth weight and polycystic ovary syndrome in adult life: a register-based study on 523,757 Danish women born 1973\u20131991. Fertil. Steril., 99(3), 777\u2013782.","journal-title":"Fertil. Steril."},{"issue":"3","key":"4461_CR116","doi-asserted-by":"publisher","first-page":"e0122050","DOI":"10.1371\/journal.pone.0122050","volume":"10","author":"SA Paschou","year":"2015","unstructured":"Paschou, S. A., et al. (2015). Birth weight and polycystic ovary syndrome in adult life: is there a causal link?. PLoS One, 10(3), e0122050.","journal-title":"PLoS One"},{"key":"4461_CR117","doi-asserted-by":"crossref","unstructured":"E. Stener-Victorin et al., Animal models to understand the etiology and pathophysiology of polycystic ovary syndrome. Endocr. Rev., 2020. 41(4)","DOI":"10.1210\/endrev\/bnaa010"},{"key":"4461_CR118","doi-asserted-by":"crossref","unstructured":"M.S. Silva, M. Prescott, R.E. Campbell, Ontogeny and reversal of brain circuit abnormalities in a preclinical model of PCOS. JCI Insight, 2018. 3(7)","DOI":"10.1172\/jci.insight.99405"},{"issue":"5","key":"4461_CR119","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/nn.3988","volume":"18","author":"BM Nugent","year":"2015","unstructured":"Nugent, B. M., et al. (2015). Brain feminization requires active repression of masculinization via DNA methylation. Nat. Neurosci., 18(5), 690\u2013697.","journal-title":"Nat. Neurosci."},{"issue":"42","key":"4461_CR120","doi-asserted-by":"publisher","first-page":"13274","DOI":"10.1523\/JNEUROSCI.3603-09.2009","volume":"29","author":"CL Wright","year":"2009","unstructured":"Wright, C. L., & McCarthy, M. M. (2009). Prostaglandin E2-induced masculinization of brain and behavior requires protein kinase A, AMPA\/kainate, and metabotropic glutamate receptor signaling. J. Neurosci., 29(42), 13274\u201313282.","journal-title":"J. Neurosci."},{"issue":"10","key":"4461_CR121","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1210\/jc.2009-0544","volume":"94","author":"M Hickey","year":"2009","unstructured":"Hickey, M., et al. (2009). The relationship between maternal and umbilical cord androgen levels and polycystic ovary syndrome in adolescence: a prospective cohort study. J. Clin. Endocrinol. Metab., 94(10), 3714\u20133720.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"4461_CR122","doi-asserted-by":"publisher","first-page":"R53","DOI":"10.1530\/JOE-20-0578","volume":"249","author":"I Salinas","year":"2021","unstructured":"Salinas, I., Sinha, N., & Sen, A. (2021). Androgen-induced epigenetic modulations in the ovary. J. Endocrinol., 249(3), R53\u2013R64.","journal-title":"J. Endocrinol."},{"issue":"5","key":"4461_CR123","first-page":"1328","volume":"79","author":"RB Barnes","year":"1994","unstructured":"Barnes, R. B., et al. (1994). Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women. J. Clin. Endocrinol. Metab., 79(5), 1328\u20131333.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"4461_CR124","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1210\/endrev\/bnab009","volume":"42","author":"RL Rosenfield","year":"2021","unstructured":"Rosenfield, R. L. (2021). Normal and premature adrenarche. Endocr. Rev., 42(6), 783\u2013814.","journal-title":"Endocr. Rev."},{"issue":"3","key":"4461_CR125","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1055\/a-1109-2630","volume":"52","author":"S Livadas","year":"2020","unstructured":"Livadas, S., et al. (2020). Unfavorable hormonal and psychologic profile in adult women with a history of premature adrenarche and Pubarche, compared to women with polycystic ovary syndrome. Horm. Metab. Res., 52(3), 179\u2013185.","journal-title":"Horm. Metab. Res."},{"issue":"5","key":"4461_CR126","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1093\/humrep\/deaa069","volume":"35","author":"Y He","year":"2020","unstructured":"He, Y., et al. (2020). Associations of childhood adiposity with menstrual irregularity and polycystic ovary syndrome in adulthood: the childhood determinants of adult health study and the Bogalusa heart study. Hum. Reprod., 35(5), 1185\u20131198.","journal-title":"Hum. Reprod."},{"issue":"1","key":"4461_CR127","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/j.1365-2605.2005.00602.x","volume":"29","author":"FM Biro","year":"2006","unstructured":"Biro, F. M., Khoury, P., & Morrison, J. A. (2006). Influence of obesity on timing of puberty. Int. J. Androl., 29(1), 272\u2013277. discussion 286\u2009\u2013\u200990.","journal-title":"Int. J. Androl."},{"issue":"2","key":"4461_CR128","first-page":"181","volume":"9","author":"WA Wattigney","year":"1999","unstructured":"Wattigney, W. A., et al. (1999). Secular trend of earlier onset of menarche with increasing obesity in black and white girls: the Bogalusa heart study. Ethn. Dis., 9(2), 181\u2013189.","journal-title":"Ethn. Dis."},{"issue":"3","key":"4461_CR129","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1136\/adc.64.3.383","volume":"64","author":"O Stark","year":"1989","unstructured":"Stark, O., Peckham, C. S., & Moynihan, C. (1989). Weight and age at menarche. Arch. Dis. Child., 64(3), 383\u2013387.","journal-title":"Arch. Dis. Child."},{"issue":"Suppl 3","key":"4461_CR130","doi-asserted-by":"publisher","first-page":"S208","DOI":"10.1542\/peds.2007-1813F","volume":"121","author":"PB Kaplowitz","year":"2008","unstructured":"Kaplowitz, P. B. (2008). Link between body fat and the timing of puberty. Pediatrics, 121(Suppl 3), S208\u2013S217.","journal-title":"Pediatrics"},{"issue":"1","key":"4461_CR131","first-page":"57","volume":"93","author":"A Garcia Ron","year":"2020","unstructured":"Garcia Ron, A., & Cuellar-Flores, I. (2020). Psychological impact of lockdown (confinement) on young children and how to mitigate its effects: rapid review of the evidence. Pediatr. (Engl Ed), 93(1), 57\u201358.","journal-title":"Pediatr. (Engl Ed)"},{"issue":"1","key":"4461_CR132","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12902-020-0497-6","volume":"20","author":"B Zhang","year":"2020","unstructured":"Zhang, B., et al. (2020). Lifestyle and environmental contributions to ovulatory dysfunction in women of polycystic ovary syndrome. BMC Endocr. Disord, 20(1), 19.","journal-title":"BMC Endocr. Disord"},{"key":"4461_CR133","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1741-7015-8-41","volume":"8","author":"H Teede","year":"2010","unstructured":"Teede, H., Deeks, A., & Moran, L. (2010). Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med., 8, 41.","journal-title":"BMC Med."},{"issue":"3","key":"4461_CR134","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1055\/s-0034-1371092","volume":"32","author":"AD Anderson","year":"2014","unstructured":"Anderson, A. D., Solorzano, C. M., & McCartney, C. R. (2014). Childhood obesity and its impact on the development of adolescent PCOS. Semin Reprod. Med., 32(3), 202\u2013213.","journal-title":"Semin Reprod. Med."},{"issue":"1","key":"4461_CR135","doi-asserted-by":"publisher","first-page":"A9","DOI":"10.1289\/ehp.1206349","volume":"121","author":"LS Birnbaum","year":"2013","unstructured":"Birnbaum, L. S. (2013). Designing safer chemicals. Environ. Health Perspect., 121(1), A9.","journal-title":"Environ. Health Perspect."},{"issue":"3\u20135","key":"4461_CR136","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jsbmb.2011.08.007","volume":"127","author":"TT Schug","year":"2011","unstructured":"Schug, T. T., et al. (2011). Endocrine disrupting chemicals and disease susceptibility. J. Steroid Biochem. Mol. Biol., 127(3\u20135), 204\u2013215.","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"2","key":"4461_CR137","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1365-2605.2010.01051.x","volume":"33","author":"A Mouritsen","year":"2010","unstructured":"Mouritsen, A., et al. (2010). Hypothesis: exposure to endocrine-disrupting chemicals May interfere with timing of puberty. Int. J. Androl., 33(2), 346\u2013359.","journal-title":"Int. J. Androl."},{"issue":"Suppl 3","key":"4461_CR138","doi-asserted-by":"publisher","first-page":"S167","DOI":"10.1542\/peds.2007-1813C","volume":"121","author":"SY Euling","year":"2008","unstructured":"Euling, S. Y., et al. (2008). Role of environmental factors in the timing of puberty. Pediatrics, 121(Suppl 3), S167\u2013S171.","journal-title":"Pediatrics"},{"issue":"5","key":"4461_CR139","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1530\/EJE-11-0876","volume":"166","author":"F Deng","year":"2012","unstructured":"Deng, F., et al. (2012). Effects of growth environments and two environmental endocrine disruptors on children with idiopathic precocious puberty. Eur. J. Endocrinol., 166(5), 803\u2013809.","journal-title":"Eur. J. Endocrinol."},{"issue":"6755","key":"4461_CR140","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/44517","volume":"401","author":"KL Howdeshell","year":"1999","unstructured":"Howdeshell, K. L., et al. (1999). Exposure to bisphenol A advances puberty. Nature, 401(6755), 763\u2013764.","journal-title":"Nature"},{"key":"4461_CR141","doi-asserted-by":"crossref","unstructured":"A. Leonardi et al., The effect of bisphenol A on puberty: A critical review of the medical literature. Int. J. Environ. Res. Public. Health, 2017. 14(9)","DOI":"10.3390\/ijerph14091044"},{"issue":"3","key":"4461_CR142","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/j.1365-2605.2012.01260.x","volume":"35","author":"H Frederiksen","year":"2012","unstructured":"Frederiksen, H., et al. (2012). High urinary phthalate concentration associated with delayed pubarche in girls. Int. J. Androl., 35(3), 216\u2013226.","journal-title":"Int. J. Androl."},{"issue":"2","key":"4461_CR143","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jpeds.2009.09.047","volume":"156","author":"JP Lomenick","year":"2010","unstructured":"Lomenick, J. P., et al. (2010). Phthalate exposure and precocious puberty in females. J. Pediatr., 156(2), 221\u2013225.","journal-title":"J. Pediatr."},{"issue":"1","key":"4461_CR144","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/s12887-019-1703-4","volume":"19","author":"MK Jung","year":"2019","unstructured":"Jung, M. K., et al. (2019). The analysis of endocrine disruptors in patients with central precocious puberty. BMC Pediatr., 19(1), 323.","journal-title":"BMC Pediatr."},{"issue":"4","key":"4461_CR145","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3109\/09513590.2013.871517","volume":"30","author":"A Rutkowska","year":"2014","unstructured":"Rutkowska, A., & Rachon, D. (2014). Bisphenol A (BPA) and its potential role in the pathogenesis of the polycystic ovary syndrome (PCOS). Gynecol. Endocrinol., 30(4), 260\u2013265.","journal-title":"Gynecol. Endocrinol."},{"issue":"1","key":"4461_CR146","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.fertnstert.2014.11.005","volume":"103","author":"S Eladak","year":"2015","unstructured":"Eladak, S., et al. (2015). A new chapter in the bisphenol A story: bisphenol S and bisphenol F are not safe alternatives to this compound. Fertil. Steril., 103(1), 11\u201321.","journal-title":"Fertil. Steril."},{"issue":"3","key":"4461_CR147","doi-asserted-by":"publisher","first-page":"E480","DOI":"10.1210\/jc.2010-1658","volume":"96","author":"E Kandaraki","year":"2011","unstructured":"Kandaraki, E., et al. (2011). Endocrine disruptors and polycystic ovary syndrome (PCOS): elevated serum levels of bisphenol A in women with PCOS. J. Clin. Endocrinol. Metab., 96(3), E480\u2013E484.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"4461_CR148","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1111\/apa.12885","volume":"104","author":"L Akin","year":"2015","unstructured":"Akin, L., et al. (2015). The endocrine disruptor bisphenol A May play a role in the aetiopathogenesis of polycystic ovary syndrome in adolescent girls. Acta Paediatr., 104(4), e171\u2013e177.","journal-title":"Acta Paediatr."},{"issue":"3","key":"4461_CR149","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/j.1365-2265.2012.04500.x","volume":"78","author":"G Tarantino","year":"2013","unstructured":"Tarantino, G., et al. (2013). Bisphenol A in polycystic ovary syndrome and its association with liver-spleen axis. Clin. Endocrinol. (Oxf), 78(3), 447\u2013453.","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"5","key":"4461_CR150","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1080\/09513590.2017.1405931","volume":"34","author":"Y Hu","year":"2018","unstructured":"Hu, Y., et al. (2018). The association between the environmental endocrine disruptor bisphenol A and polycystic ovary syndrome: a systematic review and meta-analysis. Gynecol. Endocrinol., 34(5), 370\u2013377.","journal-title":"Gynecol. Endocrinol."},{"issue":"11","key":"4461_CR151","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1001\/jama.300.11.1303","volume":"300","author":"IA Lang","year":"2008","unstructured":"Lang, I. A., et al. (2008). Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA, 300(11), 1303\u20131310.","journal-title":"JAMA"},{"issue":"1","key":"4461_CR152","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1177\/1933719116654992","volume":"24","author":"M Hewlett","year":"2017","unstructured":"Hewlett, M., et al. (2017). Prenatal exposure to endocrine disruptors: A developmental etiology for polycystic ovary syndrome. Reprod. Sci., 24(1), 19\u201327.","journal-title":"Reprod. Sci."},{"issue":"1","key":"4461_CR153","doi-asserted-by":"publisher","first-page":"27","DOI":"10.6065\/apem.2017.22.1.27","volume":"22","author":"J Park","year":"2017","unstructured":"Park, J., & Kim, J. H. (2017). Change in body mass index and insulin resistance after 1-year treatment with gonadotropin-releasing hormone agonists in girls with central precocious puberty. Ann. Pediatr. Endocrinol. Metab., 22(1), 27\u201335.","journal-title":"Ann. Pediatr. Endocrinol. Metab."},{"issue":"3","key":"4461_CR154","doi-asserted-by":"publisher","first-page":"176","DOI":"10.6065\/apem.2017.22.3.176","volume":"22","author":"JH Hur","year":"2017","unstructured":"Hur, J. H., et al. (2017). Insulin resistance and bone age advancement in girls with central precocious puberty. Ann. Pediatr. Endocrinol. Metab., 22(3), 176\u2013182.","journal-title":"Ann. Pediatr. Endocrinol. Metab."},{"issue":"2","key":"4461_CR155","doi-asserted-by":"publisher","first-page":"81","DOI":"10.6065\/apem.2018.23.2.81","volume":"23","author":"DW Kim","year":"2018","unstructured":"Kim, D. W., et al. (2018). Visceral fat thickness and its associations with pubertal and metabolic parameters among girls with precocious puberty. Ann. Pediatr. Endocrinol. Metab., 23(2), 81\u201387.","journal-title":"Ann. Pediatr. Endocrinol. Metab."},{"issue":"8","key":"4461_CR156","doi-asserted-by":"publisher","first-page":"3736","DOI":"10.1210\/jc.2010-0731","volume":"95","author":"K Sorensen","year":"2010","unstructured":"Sorensen, K., et al. (2010). Insulin sensitivity and lipid profiles in girls with central precocious puberty before and during gonadal suppression. J. Clin. Endocrinol. Metab., 95(8), 3736\u20133744.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"4461_CR157","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1515\/jpem-2020-0019","volume":"33","author":"P Satitpatanapan","year":"2020","unstructured":"Satitpatanapan, P., Jaruratanasirikul, S., & Sriplung, H. (2020). Menstrual cycle, reproductive function, body mass index, and metabolic profiles of women with former central precocious puberty: 10-20-year longitudinal cohort study in Southern Thailand. J. Pediatr. Endocrinol. Metab., 33(7), 933\u2013940.","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"11","key":"4461_CR158","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1515\/jpem-2021-0142","volume":"34","author":"CO Ramos","year":"2021","unstructured":"Ramos, C. O., et al. (2021). Anthropometric, metabolic, and reproductive outcomes of patients with central precocious puberty treated with leuprorelin acetate 3-month depot (11.25\u00a0mg). J. Pediatr. Endocrinol. Metab., 34(11), 1371\u20131377.","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"2","key":"4461_CR159","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1515\/jpem-2018-0290","volume":"32","author":"AJ Arcari","year":"2019","unstructured":"Arcari, A. J., et al. (2019). One-year treatment with gonadotropin-releasing hormone analogues does not affect body mass index, insulin sensitivity or lipid profile in girls with central precocious puberty. J. Pediatr. Endocrinol. Metab., 32(2), 181\u2013186.","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"1","key":"4461_CR160","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jpeds.2003.08.015","volume":"144","author":"L Ibanez","year":"2004","unstructured":"Ibanez, L., et al. (2004). Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome. J. Pediatr., 144(1), 23\u201329.","journal-title":"J. Pediatr."},{"issue":"8","key":"4461_CR161","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1210\/jc.2006-0336","volume":"91","author":"L Ibanez","year":"2006","unstructured":"Ibanez, L., et al. (2006). Metformin treatment to prevent early puberty in girls with precocious pubarche. J. Clin. Endocrinol. Metab., 91(8), 2888\u20132891.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"4461_CR162","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.fertnstert.2010.08.052","volume":"95","author":"L Ibanez","year":"2011","unstructured":"Ibanez, L., et al. (2011). Early Metformin therapy to delay menarche and augment height in girls with precocious pubarche. Fertil. Steril., 95(2), 727\u2013730.","journal-title":"Fertil. Steril."},{"issue":"5","key":"4461_CR163","first-page":"1390","volume":"82","author":"S Mesiano","year":"1997","unstructured":"Mesiano, S., et al. (1997). Insulin-like growth factors augment steroid production and expression of steroidogenic enzymes in human fetal adrenal cortical cells: implications for adrenal androgen regulation. J. Clin. Endocrinol. Metab., 82(5), 1390\u20131396.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"4461_CR164","first-page":"3892","volume":"81","author":"D l\u2019Allemand","year":"1996","unstructured":"l\u2019Allemand, D., et al. (1996). Insulin-like growth factors enhance steroidogenic enzyme and Corticotropin receptor messenger ribonucleic acid levels and Corticotropin steroidogenic responsiveness in cultured human adrenocortical cells. J. Clin. Endocrinol. Metab., 81(11), 3892\u20133897.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4461_CR165","doi-asserted-by":"crossref","unstructured":"E. Cela, D. De Alcubierre, E. Sbardella, Polycystic Ovary Syndrome in the Context of Pituitary Adenomas: Prevalence, Pathophysiology and Clinical Management (Clin Endocrinol (Oxf), 2024)","DOI":"10.1111\/cen.15182"},{"issue":"6","key":"4461_CR166","first-page":"2037","volume":"84","author":"P Vuguin","year":"1999","unstructured":"Vuguin, P., et al. (1999). The roles of insulin sensitivity, insulin-like growth factor I (IGF-I), and IGF-binding protein-1 and \u2013\u20093 in the hyperandrogenism of African-American and Caribbean Hispanic girls with premature adrenarche. J. Clin. Endocrinol. Metab., 84(6), 2037\u20132042.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"4461_CR167","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1210\/jcem.87.1.8143","volume":"87","author":"ME Silfen","year":"2002","unstructured":"Silfen, M. E., et al. (2002). Elevated free IGF-I levels in prepubertal Hispanic girls with premature adrenarche: relationship with hyperandrogenism and insulin sensitivity. J. Clin. Endocrinol. Metab., 87(1), 398\u2013403.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"4461_CR168","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1093\/humrep\/dew243","volume":"31","author":"S Cassar","year":"2016","unstructured":"Cassar, S., et al. (2016). Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies. Hum. Reprod., 31(11), 2619\u20132631.","journal-title":"Hum. Reprod."},{"issue":"7","key":"4461_CR169","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1210\/js.2017-00192","volume":"1","author":"M Cree-Green","year":"2017","unstructured":"Cree-Green, M., et al. (2017). Insulin Resistance, Hyperinsulinemia, and mitochondria dysfunction in Nonobese girls with polycystic ovarian syndrome. J. Endocr. Soc., 1(7), 931\u2013944.","journal-title":"J. Endocr. Soc."},{"issue":"7","key":"4461_CR170","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1210\/jc.2009-0139","volume":"94","author":"X Du","year":"2009","unstructured":"Du, X., Rosenfield, R. L., & Qin, K. (2009). KLF15 is a transcriptional regulator of the human 17beta-hydroxysteroid dehydrogenase type 5 gene. A potential link between regulation of testosterone production and fat stores in women. J. Clin. Endocrinol. Metab., 94(7), 2594\u20132601.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"4461_CR171","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1067\/mpd.2001.109603","volume":"138","author":"VD Lewy","year":"2001","unstructured":"Lewy, V. D., et al. (2001). Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome. J. Pediatr., 138(1), 38\u201344.","journal-title":"J. Pediatr."},{"issue":"6","key":"4461_CR172","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/j.fertnstert.2020.12.015","volume":"115","author":"U Ezeh","year":"2021","unstructured":"Ezeh, U., et al. (2021). Menstrual dysfunction in polycystic ovary syndrome: association with dynamic state insulin resistance rather than hyperandrogenism. Fertil. Steril., 115(6), 1557\u20131568.","journal-title":"Fertil. Steril."},{"issue":"5","key":"4461_CR173","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrendo.2018.24","volume":"14","author":"HF Escobar-Morreale","year":"2018","unstructured":"Escobar-Morreale, H. F. (2018). Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat. Rev. Endocrinol., 14(5), 270\u2013284.","journal-title":"Nat. Rev. Endocrinol."},{"issue":"9","key":"4461_CR174","doi-asserted-by":"publisher","first-page":"3327","DOI":"10.1210\/jc.2017-00947","volume":"102","author":"MW O\u2019Reilly","year":"2017","unstructured":"O\u2019Reilly, M. W., et al. (2017). AKR1C3-Mediated adipose androgen generation drives lipotoxicity in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metabolism, 102(9), 3327\u20133339.","journal-title":"J. Clin. Endocrinol. Metabolism"},{"issue":"2","key":"4461_CR175","doi-asserted-by":"publisher","first-page":"484","DOI":"10.2337\/diabetes.51.2.484","volume":"51","author":"I Ek","year":"2002","unstructured":"Ek, I., et al. (2002). A unique defect in the regulation of visceral fat cell lipolysis in the polycystic ovary syndrome as an early link to insulin resistance. Diabetes, 51(2), 484\u2013492.","journal-title":"Diabetes"},{"issue":"3","key":"4461_CR176","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1677\/joe.1.07070","volume":"192","author":"A Corbould","year":"2007","unstructured":"Corbould, A. (2007). Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women. J. Endocrinol., 192(3), 585\u2013594.","journal-title":"J. Endocrinol."},{"issue":"7","key":"4461_CR177","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/dmrr.872","volume":"24","author":"A Corbould","year":"2008","unstructured":"Corbould, A. (2008). Effects of androgens on insulin action in women: is androgen excess a component of female metabolic syndrome?. Diabetes Metab. Res. Rev., 24(7), 520\u2013532.","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"7","key":"4461_CR178","doi-asserted-by":"publisher","first-page":"E1287","DOI":"10.1210\/jc.2013-4160","volume":"99","author":"G Huang","year":"2014","unstructured":"Huang, G., et al. (2014). Testosterone dose-response relationships with cardiovascular risk markers in androgen-deficient women: a randomized, placebo-controlled trial. J. Clin. Endocrinol. Metab., 99(7), E1287\u2013E1293.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"4461_CR179","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1515\/JPEM.2007.20.1.41","volume":"20","author":"EE Littlejohn","year":"2007","unstructured":"Littlejohn, E. E., et al. (2007). Intractable early childhood obesity as the initial sign of insulin resistant hyperinsulinism and precursor of polycystic ovary syndrome. J. Pediatr. Endocrinol. Metab., 20(1), 41\u201351.","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"10","key":"4461_CR180","doi-asserted-by":"publisher","first-page":"4484","DOI":"10.1210\/en.2003-0457","volume":"144","author":"R Burcelin","year":"2003","unstructured":"Burcelin, R., et al. (2003). Gonadotropin-releasing hormone secretion from hypothalamic neurons: stimulation by insulin and potentiation by leptin. Endocrinology, 144(10), 4484\u20134491.","journal-title":"Endocrinology"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04461-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04461-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04461-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T18:02:41Z","timestamp":1765908161000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04461-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":180,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4461"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04461-y","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"6 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}